---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-056451"
form_type: "8-K"
ticker: "NTRA"
cik: "0001604821"
company_name: "Natera, Inc."
filed_at: "2022-05-05T23:59:59+00:00"
generated_at: "2026-06-25T23:43:11.651339+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Natera Q1 revenue $194.1M (+27.5% YoY), raises 2022 guidance to $790-810M

## Summary
- Product revenue $190M, up 57.8% YoY; processed 489,300 tests, up 40.5%.
- Net loss $138.6M or ($1.45) per share vs. ($0.74) a year ago.
- Raised 2022 revenue guidance from $770-790M to $790-810M.
- Board and executives elect to take 100% equity compensation for remainder of 2022.
- Signatera ADLT reimbursement increased to $3,920 per test effective April 2022.

## SEC filing metadata
- accession: 0001104659-22-056451
- form_type: 8-K
- ticker: NTRA
- cik: 0001604821
- company_name: Natera, Inc.
- filed_at: 2022-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604821/000110465922056451/0001104659-22-056451-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604821/000110465922056451/tm2214592d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-056451
- JSON: https://secwatch.observer/filing/0001104659-22-056451.json
- Plain text: https://secwatch.observer/filing/0001104659-22-056451.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.